Come up with a name for your new list and we'll add to it:
Tetra Discovery Partners raised a round of funding on June 19, 2012. Investors include
National Institutes of Health.
Tetra Discovery Partners uses structure‑guided drug design to discover mechanistically novel, allosteric inhibitors of phosphodiesterase 4 (PDE4). The company's research focuses on developing new tr…